• About TSH
    • Vision
    • Pipeline
    • Collaboration
    • Organization
    • History
    • Parent Company
    • News
  • Products
    • Prescription medication
      • Cardiovascular
      • Central Nervous
      • Gastrointestinal
      • Others
    • Patient Care
    • Report Query
  • Investors
    • Institutional Investor Conference
    • Financials
      • Monthly Revenues
      • Financial Reports
      • Annual Reports
    • Shareholder Serivces
      • Dividends
      • Shareholders' Meeting
      • List of Major Shareholders
    • Corporate Governance
      • Board of Directors
      • Audit Committee
      • Remuneration Committee
      • Major Internal Policies
      • Internal Audit
  • Careers
    • Learnings and Development
    • Join TSH
  • CSR
    • CSR Promotion Center
    • Social Participation
    • Stakeholder
  • Report Query
  • Search
  • 繁
  • EN

  1. Home
  2. Investors
  3. Corporate Governance
  4. Major Internal Policies

Menu

Investors
Corporate Governance
  • Institutional Investor Conference
  • Financials
    • Monthly Revenues
    • Financial Reports
    • Annual Reports
  • Shareholder Serivces
    • Dividends
    • Shareholders Meeting
    • List of Major Shareholders
  • Corporate Governance
    • Board of Directors
    • Audit Committee
    • Remuneration Committee
    • Major Internal Policies
    • Internal Audit

Major Internal Policies

1
Articles of Incorporation
2
Rules of Procedure for Shareholders' Meetings
3
Rules of Procedure for Board Meeting
4
Self-Evaluation of the Board of Directors
5
Audit Committee Charter
6
Remuneration Committee Charter
7
Procedures for Acquisition or Disposal of Assets
8
Procedures for Lending Funds to Other Parties
9
Procedures for Endorsement and Guarantee
10
Corporate Governance Code of Practice
11
Code of Practice for Corporate Social Responsibility
12
Ethical Corporate Management Best Practice Principles
13
Procedures for Ethical Management and Guidelines for Conduct
14
Codes of Ethical Conduct
15
Operating Procedures for Handling Internal Material Information and Preventing Insider Trading
16
Risk Management Policy and Procedure
17
Whistleblowing System

  • About TSH
  • Products
  • Investors
  • Careers
  • CSR
  • Report Query
  • Contact Us
  • TEL: +886-2-2655-8525
  • FAX: +886-2-2655-8526
  • Address:3F-1, No.3-1, Park Street, Nangang District, Taipei City, Taiwan (R.O.C)
  • Copyright © 2020 TSH Biopharm All Rights Reserved.
  • Follow us -